Matches in Wikidata for { <http://www.wikidata.org/entity/Q94463031> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q94463031 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q94463031 description "scientific article published on 29 April 2020" @default.
- Q94463031 description "wetenschappelijk artikel" @default.
- Q94463031 description "наукова стаття, опублікована 29 квітня 2020" @default.
- Q94463031 name "Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway" @default.
- Q94463031 name "Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway" @default.
- Q94463031 type Item @default.
- Q94463031 label "Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway" @default.
- Q94463031 label "Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway" @default.
- Q94463031 prefLabel "Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway" @default.
- Q94463031 prefLabel "Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway" @default.
- Q94463031 P1433 Q94463031-23061AA5-97B4-426B-AC42-54A974D11EE4 @default.
- Q94463031 P1476 Q94463031-33D1DA57-C471-404E-B164-A5430AD90ACC @default.
- Q94463031 P2093 Q94463031-11E20DE2-1503-4544-BF2A-AF1B8ED007FB @default.
- Q94463031 P2093 Q94463031-267D56CF-BD26-41B3-AECD-2A7C71C00E64 @default.
- Q94463031 P2093 Q94463031-569F8BD1-B777-47C0-AA48-0EFAB3D8EACE @default.
- Q94463031 P2093 Q94463031-78E82EBF-4E31-48AD-A88A-74667031BD72 @default.
- Q94463031 P31 Q94463031-1976DC98-0F44-46B8-A4B2-D776D0D90280 @default.
- Q94463031 P356 Q94463031-3BE77B93-C7F5-4884-88B5-4A2A3452200D @default.
- Q94463031 P577 Q94463031-D38CE1A2-3E63-43FB-B5AA-29C5A2D6A252 @default.
- Q94463031 P698 Q94463031-59EF31AE-CDEB-4CF6-ABB9-083B3528AE9E @default.
- Q94463031 P921 Q94463031-AFAAD81F-A3F8-4C26-BBDE-A3FF1825D32A @default.
- Q94463031 P921 Q94463031-D2047B7D-0B84-453A-B44C-DC7EF567ADEF @default.
- Q94463031 P356 FJ.201902055R @default.
- Q94463031 P698 32350920 @default.
- Q94463031 P1433 Q520194 @default.
- Q94463031 P1476 "Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway" @default.
- Q94463031 P2093 "Bo Li" @default.
- Q94463031 P2093 "Changlong Bi" @default.
- Q94463031 P2093 "Yili Fu" @default.
- Q94463031 P2093 "Zheqi Zhang" @default.
- Q94463031 P31 Q13442814 @default.
- Q94463031 P356 "10.1096/FJ.201902055R" @default.
- Q94463031 P577 "2020-04-29T00:00:00Z" @default.
- Q94463031 P698 "32350920" @default.
- Q94463031 P921 Q416554 @default.
- Q94463031 P921 Q844935 @default.